4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000118
SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $91.49 ($457,434)
- SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
- SVP, GEN COUNSEL & CORP SEC gave up 475 shares (to pay taxes)
- SVP, GEN COUNSEL & CORP SEC gave 110 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Gift 10b5-1 | −110 | 28,697 | D | ||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Option exercise 10b5-1 | +5,000 | $21.41 | $107,050 | 33,697 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Sale 10b5-1 | −1,435 | $90.16 | $129,384 | 32,262 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Sale 10b5-1 | −3,177 | $91.91 | $292,004 | 29,085 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Sale 10b5-1 | −388 | $92.90 | $36,046 | 28,697 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-09 | Shares withheld for taxes 10b5-1 | −475 | $92.06 | $43,729 | 28,222 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-12-05 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 159,497 | D | ||
| Open-market sales · 5,000 sh · avg $91.49 · $457,434 | |||||||
Loading xslF345X05/wk-form4_1733786878.xml…